Vaccine Therapy and GM-CSF in Treating Patients With Progressive Non-Hodgkin's Lymphoma
Stopped early · Phase 2
Conditions studied: Lymphoma
In brief
RATIONALE: Vaccines made from a person's cancer cells may make the body build an effective immune response to kill cancer cells. Colony-stimulating factors, such as GM-CSF, may increase the number of immune cells found in bone marrow or peripheral blood and may stimulate the immune system in different ways and stop cancer cells from growing. PURPOSE: This phase II trial is studying how well giving vaccine therapy together with GM-CSF works in treating patients with progressive B-cell non-Hodgkin's lymphoma.
Key facts
- Study ID
- NCT00104819
- Run by
- Favrille
- People needed
- 238
- Starts
- 2004-09-01
- Last updated by the study team
- 2013-08-02
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Tower Cancer Research Foundation — Beverly Hills, California, United States
- Rebecca and John Moores UCSD Cancer Center — La Jolla, California, United States
- Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center — Los Angeles, California, United States
- Kaiser Permanente Medical Center - Kaiser Foundation Hospital - San Diego — San Diego, California, United States
- Sharp Memorial Hospital Cancer Center — San Diego, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco, California, United States
- Stanford Cancer Center — Stanford, California, United States
- Kaiser Permanente Medical Center - Vallejo — Vallejo, California, United States
- Rocky Mountain Cancer Centers - Denver Midtown — Denver, Colorado, United States
- Helen F. Graham Cancer Center at Christiana Hospital — Newark, Delaware, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center — Washington D.C., District of Columbia, United States
- Center for Hematology-Oncology - Boca Raton — Boca Raton, Florida, United States
- H. Lee Moffitt Cancer Center and Research Institute at University of South Florida — Tampa, Florida, United States
- Kootenai Cancer Center - Coeur d'Alene — Coeur d'Alene, Idaho, United States
- Robert H. Lurie Comprehensive Cancer Center at Northwestern University — Chicago, Illinois, United States
- Rush Cancer Institute at Rush University Medical Center — Chicago, Illinois, United States
- Indiana University Melvin and Bren Simon Cancer Center — Indianapolis, Indiana, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center — Kansas City, Kansas, United States
- Lucille P. Markey Cancer Center at University of Kentucky — Lexington, Kentucky, United States
- Ochsner Cancer Institute at Ochsner Clinic Foundation — New Orleans, Louisiana, United States
- Greater Baltimore Medical Center Cancer Center — Baltimore, Maryland, United States
- Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute — Boston, Massachusetts, United States
- Josephine Ford Cancer Center at Henry Ford Hospital — Detroit, Michigan, United States
- Mayo Clinic Cancer Center — Rochester, Minnesota, United States
- UAB Comprehensive Cancer Center — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.